BRAF c.771G>C ;(p.Q257H)

Variant ID: 7-140501301-C-G

NM_004333.4(BRAF):c.771G>C;(p.Q257H)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.

British Journal Of Cancer
Brodin, Bertha A BA; Wennerberg, Krister K; Lidbrink, Elisabet E; Brosjö, Otte O; Potdar, Swapnil S; Wilson, Jennifer N JN; Ma, Limin L; Moens, Lotte N LN; Hesla, Asle A; Porovic, Edvin E; Bernhardsson, Edvin E; Papakonstantinou, Antroula A; Bauer, Henrik H; Tsagkozis, Panagiotis P; von Sivers, Karin K; Wejde, Johan J; Östling, Päivi P; Kallioniemi, Olli O; Stragliotto, Christina Linder CL
Publication Date: 2019-02

Variant appearance in text: BRAF: Q257H
PubMed Link: 30745580
Variant Present in the following documents:
  • Main text
  • 41416_2018_Article_359.pdf
View BVdb publication page



Mutational heterogeneity in non-serous ovarian cancers.

Scientific Reports
Teer, Jamie K JK; Yoder, Sean S; Gjyshi, Anxhela A; Nicosia, Santo V SV; Zhang, Chaomei C; Monteiro, Alvaro N A ANA
Publication Date: 2017-08-29

Variant appearance in text: BRAF: Q257H
PubMed Link: 28852190
Variant Present in the following documents:
  • Main text
  • 41598_2017_Article_10432.pdf
View BVdb publication page